VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q37367472 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000320.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q37367472‏
024 ‎‡a 0000-0001-9222-3882‏ ‎‡2 orcid‏
024 ‎‡a 6602647416‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q37367472‏
100 0 ‎‡a Ana Cristina Simões E Silva‏ ‎‡c investigadora‏ ‎‡9 ast‏
375 ‎‡a 2‏ ‎‡2 iso5218‏
400 0 ‎‡a Ana Cristina Simões E Silva‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Ana Cristina Simões E Silva‏ ‎‡c investigadora‏ ‎‡9 es‏
400 0 ‎‡a Ana Cristina Simões E. Silva‏ ‎‡c ricercatrice‏ ‎‡9 it‏
400 0 ‎‡a Ana Cristina Simões E Silva‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
400 0 ‎‡a Ana Cristina Simões E Silva‏ ‎‡c investigadora‏ ‎‡9 pt‏
670 ‎‡a Author's 2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus‏
670 ‎‡a Author's A clinical predictive model of renal injury in children with congenital solitary functioning kidney‏
670 ‎‡a Author's A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis‏
670 ‎‡a Author's A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract‏
670 ‎‡a Author's A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract‏
670 ‎‡a Author's A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program‏
670 ‎‡a Author's A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome‏
670 ‎‡a Author's A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates‏
670 ‎‡a Author's ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis‏
670 ‎‡a Author's ACE2–angiotensin-‏
670 ‎‡a Author's ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats‏
670 ‎‡a Author's ACE2/Angiotensin-(1-7)/Mas receptor axis in human cancer: Potential role for pediatric tumors‏
670 ‎‡a Author's Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates‏
670 ‎‡a Author's ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation‏
670 ‎‡a Author's Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas‏
670 ‎‡a Author's Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors‏
670 ‎‡a Author's Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney‏
670 ‎‡a Author's Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress‏
670 ‎‡a Author's Angiotensins‏
670 ‎‡a Author's Anthropometric and biochemical profile of children and adolescents with chronic kidney disease in a predialysis pediatric interdisciplinary program.‏
670 ‎‡a Author's Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis‏
670 ‎‡a Author's Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.‏
670 ‎‡a Author's Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso‏
670 ‎‡a Author's Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging‏
670 ‎‡a Author's Association between dyslipidemia and CCL2 in patients undergoing hemodialysis‏
670 ‎‡a Author's Association of angiotensin type 2 receptor gene polymorphisms with ureteropelvic junction obstruction in Brazilian patients‏
670 ‎‡a Author's Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏
670 ‎‡a Author's Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents‏
670 ‎‡a Author's Avaliação da dor em neonatologia‏
670 ‎‡a Author's [Bartter' syndrome: five cases with different clinical expression]‏
670 ‎‡a Author's Bartter's syndrome: clinical findings, genetic causes and therapeutic approach‏
670 ‎‡a Author's Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease‏
670 ‎‡a Author's Beneficial effects of the activation of the angiotensin-‏
670 ‎‡a Author's Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.‏
670 ‎‡a Author's Biomarkers in vesicoureteral reflux: an overview‏
670 ‎‡a Author's Bone disease and cytokines in idiopathic hypercalciuria: a review‏
670 ‎‡a Author's Cell-derived microparticles and von Willebrand factor in Brazilian renal transplant recipients‏
670 ‎‡a Author's Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease‏
670 ‎‡a Author's Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).‏
670 ‎‡a Author's Characterization of an experimental model of progressive renal disease in rats‏
670 ‎‡a Author's Chemokines as Potential Markers in Pediatric Renal Diseases‏
670 ‎‡a Author's Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity‏
670 ‎‡a Author's Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-‏
670 ‎‡a Author's Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease‏
670 ‎‡a Author's Citocinas e quimiocinas no transplante renal‏
670 ‎‡a Author's Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome‏
670 ‎‡a Author's Clinical course of 822 children with prenatally detected nephrouropathies‏
670 ‎‡a Author's Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program‏
670 ‎‡a Author's Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children‏
670 ‎‡a Author's Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?‏
670 ‎‡a Author's Congenital anomalies of the kidney and urinary tract: an embryogenetic review‏
670 ‎‡a Author's Current knowledge on esophageal atresia‏
670 ‎‡a Author's Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis.‏
670 ‎‡a Author's Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases‏
670 ‎‡a Author's Dental Alterations in Renal Tubular Acidosis: Case Reports‏
670 ‎‡a Author's Dental findings in Brazilian patients with Fanconi syndrome‏
670 ‎‡a Author's Dental Manifestations in Two Patients With Bartter’s Syndrome‏
670 ‎‡a Author's Development of hepatorenal syndrome in bile duct ligated rats‏
670 ‎‡a Author's Diagnostic accuracy of renal pelvic dilatation for detecting surgically managed ureteropelvic junction obstruction‏
670 ‎‡a Author's Diagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologists‏
670 ‎‡a Author's Distal renal tubular acidosis: genetic causes and management‏
670 ‎‡a Author's Diuresis and natriuresis produced by long term administration of a selective Angiotensin-‏
670 ‎‡a Author's Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats‏
670 ‎‡a Author's Early awakening and extubation with remifentanil in ventilated premature neonates‏
670 ‎‡a Author's Early changes in adipokines from overweight to obesity in children and adolescents.‏
670 ‎‡a Author's Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns‏
670 ‎‡a Author's Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease‏
670 ‎‡a Author's Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients‏
670 ‎‡a Author's Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-‏
670 ‎‡a Author's Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats‏
670 ‎‡a Author's Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile‏
670 ‎‡a Author's Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏
670 ‎‡a Author's Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients‏
670 ‎‡a Author's Evidence for a Physiological Role of Angiotensin-‏
670 ‎‡a Author's Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance‏
670 ‎‡a Author's Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome‏
670 ‎‡a Author's Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia‏
670 ‎‡a Author's First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection.‏
670 ‎‡a Author's Frequency of overweight and obesity in children and adolescents with autism and attention deficit/hyperactivity disorder‏
670 ‎‡a Author's Genetic deletion of the angiotensin-‏
670 ‎‡a Author's Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.‏
670 ‎‡a Author's Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors‏
670 ‎‡a Author's Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.‏
670 ‎‡a Author's Hemostatic changes in patients with end stage renal disease undergoing hemodialysis‏
670 ‎‡a Author's Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients‏
670 ‎‡a Author's Hepatorenal syndrome in children: a review‏
670 ‎‡a Author's Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies‏
670 ‎‡a Author's Immune-Based Therapies for Traumatic Brain Injury: Insights from pre-clinical studies‏
670 ‎‡a Author's Immune markers in the RASopathy neurofibromatosis type 1.‏
670 ‎‡a Author's Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria‏
670 ‎‡a Author's Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study.‏
670 ‎‡a Author's Immunoglobulin A nephropathy: a pathophysiology view‏
670 ‎‡a Author's Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients‏
670 ‎‡a Author's [In memoriam: Professor José Silvério Santos Diniz‏
670 ‎‡a Author's [In memoriam: Professor José Silvério Santos Diniz (1935-2011)].‏
670 ‎‡a Author's Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome‏
670 ‎‡a Author's Inflamação na doença renal crônica: papel de citocinas‏
670 ‎‡a Author's Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review.‏
670 ‎‡a Author's Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis‏
670 ‎‡a Author's Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease‏
670 ‎‡a Author's Interactions between local renin angiotensin system and nitric oxide in the brain of Trypanosoma cruzi infected rats‏
670 ‎‡a Author's Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?‏
670 ‎‡a Author's Is remifentanil an option for premedication for neonatal endotracheal intubation?‏
670 ‎‡a Author's Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences‏
670 ‎‡a Author's Kidney-brain axis inflammatory cross-talk: from bench to bedside‏
670 ‎‡a Author's Liddle's syndrome: late diagnosis of a rare cause of arterial hypertension‏
670 ‎‡a Author's Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia‏
670 ‎‡a Author's Lower circulating levels of angiotensin-converting enzyme‏
670 ‎‡a Author's Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia‏
670 ‎‡a Author's Mas and Inflammation‏
670 ‎‡a Author's Mas in the Kidney‏
670 ‎‡a Author's Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo‏
670 ‎‡a Author's Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏
670 ‎‡a Author's Morphine versus remifentanil for intubating preterm neonates‏
670 ‎‡a Author's Neuropsychiatric disorders and renal diseases: an update‏
670 ‎‡a Author's Neurotrophic Factors in Parkinson's Disease: What have we Learned from Pre-Clinical and Clinical Studies?‏
670 ‎‡a Author's New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva's technique‏
670 ‎‡a Author's Newer Doppler echocardiography techniques in assessment of heart function in obese patients‏
670 ‎‡a Author's Nonpeptide AVE 0991 is an angiotensin-‏
670 ‎‡a Author's Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.‏
670 ‎‡a Author's Nutritional evaluation of children with chronic cholestatic disease‏
670 ‎‡a Author's Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies‏
670 ‎‡a Author's PAX2 polymorphisms and congenital abnormalities of the kidney and urinary tract in a Brazilian pediatric population: evidence for a role in vesicoureteral reflux‏
670 ‎‡a Author's Pediatric lupus nephritis‏
670 ‎‡a Author's Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease‏
670 ‎‡a Author's Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica‏
670 ‎‡a Author's Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease‏
670 ‎‡a Author's Physical Exercise and ACE2-Angiotensin-‏
670 ‎‡a Author's Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System‏
670 ‎‡a Author's Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals.‏
670 ‎‡a Author's Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria‏
670 ‎‡a Author's Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study‏
670 ‎‡a Author's Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules‏
670 ‎‡a Author's Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts‏
670 ‎‡a Author's Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease‏
670 ‎‡a Author's Predictive factors of chronic kidney disease in severe vesicoureteral reflux‏
670 ‎‡a Author's Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme‏
670 ‎‡a Author's Primary versus secondary hypertension in children followed up at an outpatient tertiary unit‏
670 ‎‡a Author's Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine‏
670 ‎‡a Author's Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology‏
670 ‎‡a Author's RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders‏
670 ‎‡a Author's Recent advances in the angiotensin-converting enzyme 2-angiotensin‏
670 ‎‡a Author's Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.‏
670 ‎‡a Author's Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis‏
670 ‎‡a Author's Relationship between angiotensin-‏
670 ‎‡a Author's Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis‏
670 ‎‡a Author's Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome‏
670 ‎‡a Author's Renal actions of angiotensin-‏
670 ‎‡a Author's Renal actions of angiotensin-(1-7).‏
670 ‎‡a Author's Renal function in transgenic rats expressing an angiotensin-‏
670 ‎‡a Author's Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein‏
670 ‎‡a Author's Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade‏
670 ‎‡a Author's Renin-angiotensin system and Alzheimer's disease pathophysiology: From the potential interactions to therapeutic perspectives‏
670 ‎‡a Author's Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence‏
670 ‎‡a Author's Renin angiotensin system in liver diseases: Friend or foe?‏
670 ‎‡a Author's Renin-angiotensin system in the pathogenesis of liver fibrosis‏
670 ‎‡a Author's Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19‏
670 ‎‡a Author's Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury.‏
670 ‎‡a Author's Risk factors for early onset of diabetic nephropathy in pediatric type 1 diabetes‏
670 ‎‡a Author's Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux.‏
670 ‎‡a Author's Risk of hypertension in primary vesicoureteral reflux‏
670 ‎‡a Author's [Sedation and analgesia in neonatology.].‏
670 ‎‡a Author's Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis‏
670 ‎‡a Author's Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients‏
670 ‎‡a Author's Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease‏
670 ‎‡a Author's Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract‏
670 ‎‡a Author's Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy.‏
670 ‎‡a Author's T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome‏
670 ‎‡a Author's The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research‏
670 ‎‡a Author's The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏
670 ‎‡a Author's The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update‏
670 ‎‡a Author's The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy‏
670 ‎‡a Author's The pregnancy-induced increase of plasma angiotensin-‏
670 ‎‡a Author's The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes‏
670 ‎‡a Author's The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves‏
670 ‎‡a Author's The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease‏
670 ‎‡a Author's The Renin Angiotensin System and Bipolar Disorder: A Systematic Review‏
670 ‎‡a Author's The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence‏
670 ‎‡a Author's The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-‏
670 ‎‡a Author's The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)‏
670 ‎‡a Author's The renin angiotensin system in childhood hypertension: selective increase of angiotensin-‏
670 ‎‡a Author's The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.‏
670 ‎‡a Author's The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood‏
670 ‎‡a Author's The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies‏
670 ‎‡a Author's The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator‏
670 ‎‡a Author's The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders‏
670 ‎‡a Author's Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter's Syndrome‏
670 ‎‡a Author's Update on the approach of urinary tract infection in childhood‏
670 ‎‡a Author's Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study‏
670 ‎‡a Author's Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.‏
670 ‎‡a Author's Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies‏
670 ‎‡a Author's Urinary tract infection in pediatrics: an overview‏
670 ‎‡a Author's Uromodulin: a new biomarker of fetal renal function?‏
670 ‎‡a Author's Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme‏
670 ‎‡a Author's Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report‏
670 ‎‡a Author's Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study‏
670 ‎‡a Author's Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis‏
670 ‎‡a Author's Zika virus challenges for neuropsychiatry‏
909 ‎‡a (orcid) 0000000192223882‏ ‎‡9 1‏
909 ‎‡a (scopus) 6602647416‏ ‎‡9 1‏
912 ‎‡a authorcorrectionthecopynumbervariationlandscapeofcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A Author Correction: The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏ ‎‡9 1‏
912 ‎‡a copynumbervariationlandscapeofcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A The copy number variation landscape of congenital anomalies of the kidney and urinary tract‏ ‎‡9 1‏
919 ‎‡a vancomycinassociatednephrotoxicityinnoncriticallyillpatientsadmittedinabrazilianpublichospitalaprospectivecohortstudy‏ ‎‡A Vancomycin-associated nephrotoxicity in non-critically ill patients admitted in a Brazilian public hospital: A prospective cohort study‏ ‎‡9 1‏
919 ‎‡a wholeexomesequencingasadiagnostictoolfordistalrenaltubularacidosis‏ ‎‡A Whole-exome sequencing as a diagnostic tool for distal renal tubular acidosis‏ ‎‡9 1‏
919 ‎‡a zikaviruschallengesforneuropsychiatry‏ ‎‡A Zika virus challenges for neuropsychiatry‏ ‎‡9 1‏
919 ‎‡a 2020updateonthereninangiotensinaldosteronesysteminpediatrickidneydiseaseanditsinteractionswithcoronavirus‏ ‎‡A 2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus‏ ‎‡9 1‏
919 ‎‡a clinicalpredictivemodelofrenalinjuryinchildrenwithcongenitalsolitaryfunctioningkidney‏ ‎‡A A clinical predictive model of renal injury in children with congenital solitary functioning kidney‏ ‎‡9 1‏
919 ‎‡a clinicalpredictivemodelofrenalinjuryinchildrenwithisolatedantenatalhydronephrosis‏ ‎‡A A clinical predictive model of renal injury in children with isolated antenatal hydronephrosis‏ ‎‡9 1‏
919 ‎‡a predictivemodelofchronickidneydiseaseinpatientswithcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A A predictive model of chronic kidney disease in patients with congenital anomalies of the kidney and urinary tract‏ ‎‡9 1‏
919 ‎‡a predictivemodelofpostnatalsurgicalinterventioninchildrenwithprenatallydetectedcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A A Predictive Model of Postnatal Surgical Intervention in Children With Prenatally Detected Congenital Anomalies of the Kidney and Urinary Tract‏ ‎‡9 1‏
919 ‎‡a predictivemodelofprogressionofckdtoesrdinapredialysispediatricinterdisciplinaryprogram‏ ‎‡A A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program‏ ‎‡9 1‏
919 ‎‡a predictivemodelofprogressivechronickidneydiseaseinidiopathicnephroticsyndrome‏ ‎‡A A predictive model of progressive chronic kidney disease in idiopathic nephrotic syndrome‏ ‎‡9 1‏
919 ‎‡a randomizedcontrolledtrialofthelaryngealmaskairwayforsurfactantadministrationinneonates‏ ‎‡A A randomized controlled trial of the laryngeal mask airway for surfactant administration in neonates‏ ‎‡9 1‏
919 ‎‡a aceinhibitionace2andangiotensin17axisinkidneyandcardiacinflammationandfibrosis‏ ‎‡A ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis‏ ‎‡9 1‏
919 ‎‡a ace2angiotensin‏ ‎‡A ACE2–angiotensin-‏ ‎‡9 1‏
919 ‎‡a ace2angiotensin17masaxisinrenalischaemiareperfusioninjuryinrats‏ ‎‡A ACE2–angiotensin-(1–7)–Mas axis in renal ischaemia/reperfusion injury in rats‏ ‎‡9 1‏
919 ‎‡a ace2angiotensin17masreceptoraxisinhumancancerpotentialroleforpediatrictumors‏ ‎‡A ACE2/Angiotensin-(1-7)/Mas receptor axis in human cancer: Potential role for pediatric tumors‏ ‎‡9 1‏
919 ‎‡a actionofapancreatinandanaspergillusoryzaeproteaseonwheyproteinscorrelationamongthemethodsofanalysisoftheenzymatichydrolysates‏ ‎‡A Action of a pancreatin and an Aspergillus oryzae protease on whey proteins: correlation among the methods of analysis of the enzymatic hydrolysates‏ ‎‡9 1‏
919 ‎‡a adamts13andvonwillebrandfactorassessmentbeforeandafterkidneytransplantation‏ ‎‡A ADAMTS13 and Von Willebrand factor assessment before and after kidney transplantation‏ ‎‡9 1‏
919 ‎‡a angiotensin17isanendogenousligandforthegproteincoupledreceptormas‏ ‎‡A Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas‏ ‎‡9 1‏
919 ‎‡a angiotensin17stimulateswatertransportinratinnermedullarycollectingductevidenceforinvolvementofvasopressinv2receptors‏ ‎‡A Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors‏ ‎‡9 1‏
919 ‎‡a angiotensinconvertingenzyme2angiotensin17andreceptormasaxisinthekidney‏ ‎‡A Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney‏ ‎‡9 1‏
919 ‎‡a angiotensinconvertingenzymeinhibitionchangesthemetabolicresponsetoneuroglucopenicstress‏ ‎‡A Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress‏ ‎‡9 1‏
919 ‎‡a angiotensins‏ ‎‡A Angiotensins‏ ‎‡9 1‏
919 ‎‡a anthropometricandbiochemicalprofileofchildrenandadolescentswithchronickidneydiseaseinapredialysispediatricinterdisciplinaryprogram‏ ‎‡A Anthropometric and biochemical profile of children and adolescents with chronic kidney disease in a predialysis pediatric interdisciplinary program.‏ ‎‡9 1‏
919 ‎‡a antiinflammatoryeffectsoftheactivationoftheangiotensin17receptormasinexperimentalmodelsofarthritis‏ ‎‡A Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis‏ ‎‡9 1‏
919 ‎‡a anxietydepressionresilienceandqualityoflifeinchildrenandadolescentswithpredialysischronickidneydisease‏ ‎‡A Anxiety, depression, resilience and quality of life in children and adolescents with pre-dialysis chronic kidney disease.‏ ‎‡9 1‏
919 ‎‡a aplicacaodabiologiamolecularnaabordagemdasindromedebartterrelatodecaso‏ ‎‡A Aplicação da biologia molecular na abordagem da síndrome de Bartter: relato de caso‏ ‎‡9 1‏
919 ‎‡a assessingpreclinicalventriculardysfunctioninobesechildrenandadolescentsthevalueofspeckletrackingimaging‏ ‎‡A Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging‏ ‎‡9 1‏
919 ‎‡a associationbetweendyslipidemiaandccl2inpatientsundergoinghemodialysis‏ ‎‡A Association between dyslipidemia and CCL2 in patients undergoing hemodialysis‏ ‎‡9 1‏
919 ‎‡a associationofangiotensintype2receptorgenepolymorphismswithureteropelvicjunctionobstructioninbrazilianpatients‏ ‎‡A Association of angiotensin type 2 receptor gene polymorphisms with ureteropelvic junction obstruction in Brazilian patients‏ ‎‡9 1‏
919 ‎‡a autoimmunehepatitisandautoimmunehepatitisoverlapwithsclerosingcholangitisimmunophenotypemarkersinchildrenandadolescents‏ ‎‡A Autoimmune Hepatitis and Autoimmune Hepatitis Overlap With Sclerosing Cholangitis: Immunophenotype Markers in Children and Adolescents‏ ‎‡9 1‏
919 ‎‡a avaliacaodadoremneonatologia‏ ‎‡A Avaliação da dor em neonatologia‏ ‎‡9 1‏
919 ‎‡a barttersyndrome5caseswithdifferentclinicalexpression‏ ‎‡A [Bartter' syndrome: five cases with different clinical expression]‏ ‎‡9 1‏
919 ‎‡a bartterssyndromeclinicalfindingsgeneticcausesandtherapeuticapproach‏ ‎‡A Bartter's syndrome: clinical findings, genetic causes and therapeutic approach‏ ‎‡9 1‏
919 ‎‡a behavioraldisordersandlowqualityoflifeinchildrenandadolescentswithchronickidneydisease‏ ‎‡A Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease‏ ‎‡9 1‏
919 ‎‡a beneficialeffectsoftheactivationoftheangiotensin‏ ‎‡A Beneficial effects of the activation of the angiotensin-‏ ‎‡9 1‏
919 ‎‡a beneficialeffectsoftheactivationoftheangiotensin17masreceptorinamurinemodelofadriamycininducednephropathy‏ ‎‡A Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.‏ ‎‡9 1‏
919 ‎‡a biomarkersinvesicoureteralrefluxanoverview‏ ‎‡A Biomarkers in vesicoureteral reflux: an overview‏ ‎‡9 1‏
919 ‎‡a bonediseaseandcytokinesinidiopathichypercalciuriaareview‏ ‎‡A Bone disease and cytokines in idiopathic hypercalciuria: a review‏ ‎‡9 1‏
919 ‎‡a cellderivedmicroparticlesandvonwillebrandfactorinbrazilianrenaltransplantrecipients‏ ‎‡A Cell-derived microparticles and von Willebrand factor in Brazilian renal transplant recipients‏ ‎‡9 1‏
919 ‎‡a cerebrospinalfluidlevelsofangiotensinconvertingenzymeareassociatedwithamyloidβ42burdeninalzheimersdisease‏ ‎‡A Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-β42 Burden in Alzheimer’s Disease‏ ‎‡9 1‏
919 ‎‡a characterizationofanewselectiveantagonistforangiotensin17500pro7angiotensin17‏ ‎‡A Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7).‏ ‎‡9 1‏
919 ‎‡a characterizationofanexperimentalmodelofprogressiverenaldiseaseinrats‏ ‎‡A Characterization of an experimental model of progressive renal disease in rats‏ ‎‡9 1‏
919 ‎‡a chemokinesaspotentialmarkersinpediatricrenaldiseases‏ ‎‡A Chemokines as Potential Markers in Pediatric Renal Diseases‏ ‎‡9 1‏
919 ‎‡a childhoodobesityevidenceofanassociationbetweenplasminogenactivatorinhibitor1levelsandvisceraladiposity‏ ‎‡A Childhood obesity: evidence of an association between plasminogen activator inhibitor-1 levels and visceral adiposity‏ ‎‡9 1‏
919 ‎‡a circulatingreninangiotensinsysteminchildhoodchronicrenalfailuremarkedincreaseofangiotensin‏ ‎‡A Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-‏ ‎‡9 1‏
919 ‎‡a circulatingreninangiotensinsysteminchildhoodchronicrenalfailuremarkedincreaseofangiotensin17inendstagerenaldisease‏ ‎‡A Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal Disease‏ ‎‡9 1‏
919 ‎‡a citocinasequimiocinasnotransplanterenal‏ ‎‡A Citocinas e quimiocinas no transplante renal‏ ‎‡9 1‏
919 ‎‡a clinicalcharacteristicsandprognosisinchildrenandadolescentswithautoimmunehepatitisandoverlapsyndrome‏ ‎‡A Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome‏ ‎‡9 1‏
919 ‎‡a clinicalcourseof822childrenwithprenatallydetectednephrouropathies‏ ‎‡A Clinical course of 822 children with prenatally detected nephrouropathies‏ ‎‡9 1‏
919 ‎‡a clinicaloutcomeofchildrenwithchronickidneydiseaseinapredialysisinterdisciplinaryprogram‏ ‎‡A Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program‏ ‎‡9 1‏
919 ‎‡a combineduseoflatephasedimercaptosuccinicacidrenalscintigraphyandultrasoundas1linescreeningafterurinarytractinfectioninchildren‏ ‎‡A Combined Use of Late Phase Dimercapto-Succinic Acid Renal Scintigraphy and Ultrasound as First Line Screening After Urinary Tract Infection in Children‏ ‎‡9 1‏
919 ‎‡a comparisonofbrazilianresearchersinclinicalmedicinearecriteriaforrankingwelladjusted‏ ‎‡A Comparison of Brazilian researchers in clinical medicine: are criteria for ranking well-adjusted?‏ ‎‡9 1‏
919 ‎‡a congenitalanomaliesofthekidneyandurinarytractanembryogeneticreview‏ ‎‡A Congenital anomalies of the kidney and urinary tract: an embryogenetic review‏ ‎‡9 1‏
919 ‎‡a currentknowledgeonesophagealatresia‏ ‎‡A Current knowledge on esophageal atresia‏ ‎‡9 1‏
919 ‎‡a cytokinesignatureinendstagerenaldiseasepatientsonhemodialysis‏ ‎‡A Cytokine Signature in End-Stage Renal Disease Patients on Hemodialysis.‏ ‎‡9 1‏
919 ‎‡a cytokinesinchronickidneydiseasepotentiallinkofmcp1anddyslipidemiainglomerulardiseases‏ ‎‡A Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases‏ ‎‡9 1‏
919 ‎‡a dentalalterationsinrenaltubularacidosiscasereports‏ ‎‡A Dental Alterations in Renal Tubular Acidosis: Case Reports‏ ‎‡9 1‏
919 ‎‡a dentalfindingsinbrazilianpatientswithfanconisyndrome‏ ‎‡A Dental findings in Brazilian patients with Fanconi syndrome‏ ‎‡9 1‏
919 ‎‡a dentalmanifestationsin2patientswithbartterssyndrome‏ ‎‡A Dental Manifestations in Two Patients With Bartter’s Syndrome‏ ‎‡9 1‏
919 ‎‡a developmentofhepatorenalsyndromeinbileductligatedrats‏ ‎‡A Development of hepatorenal syndrome in bile duct ligated rats‏ ‎‡9 1‏
919 ‎‡a diagnosticaccuracyofrenalpelvicdilatationfordetectingsurgicallymanagedureteropelvicjunctionobstruction‏ ‎‡A Diagnostic accuracy of renal pelvic dilatation for detecting surgically managed ureteropelvic junction obstruction‏ ‎‡9 1‏
919 ‎‡a diagnosticcriteriaforautoimmunehepatitisinchildrenachallengeforpediatrichepatologists‏ ‎‡A Diagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologists‏ ‎‡9 1‏
919 ‎‡a distalrenaltubularacidosisgeneticcausesandmanagement‏ ‎‡A Distal renal tubular acidosis: genetic causes and management‏ ‎‡9 1‏
919 ‎‡a diuresisandnatriuresisproducedbylongtermadministrationofaselectiveangiotensin‏ ‎‡A Diuresis and natriuresis produced by long term administration of a selective Angiotensin-‏ ‎‡9 1‏
919 ‎‡a diuresisandnatriuresisproducedbylongtermadministrationofaselectiveangiotensin17antagonistinnormotensiveandhypertensiverats‏ ‎‡A Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1–7) antagonist in normotensive and hypertensive rats‏ ‎‡9 1‏
919 ‎‡a earlyawakeningandextubationwithremifentanilinventilatedprematureneonates‏ ‎‡A Early awakening and extubation with remifentanil in ventilated premature neonates‏ ‎‡9 1‏
919 ‎‡a earlychangesinadipokinesfromoverweighttoobesityinchildrenandadolescents‏ ‎‡A Early changes in adipokines from overweight to obesity in children and adolescents.‏ ‎‡9 1‏
919 ‎‡a earlyriskfactorsforneonatalmortalityincakutanalysisof524affectednewborns‏ ‎‡A Early risk factors for neonatal mortality in CAKUT: analysis of 524 affected newborns‏ ‎‡9 1‏
919 ‎‡a effectofblockadeofnitricoxideinhearttissuelevelsofreninangiotensinsystemcomponentsinacuteexperimentalchagasdisease‏ ‎‡A Effect of blockade of nitric oxide in heart tissue levels of Renin Angiotensin System components in acute experimental Chagas disease‏ ‎‡9 1‏
919 ‎‡a effectofpropranololonthesplanchnicandperipheralreninangiotensinsystemincirrhoticpatients‏ ‎‡A Effect of propranolol on the splanchnic and peripheral renin angiotensin system in cirrhotic patients‏ ‎‡9 1‏
919 ‎‡a effectofselectiveangiotensinantagonistsontheantidiuresisproducedbyangiotensin‏ ‎‡A Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-‏ ‎‡9 1‏
919 ‎‡a effectofselectiveangiotensinantagonistsontheantidiuresisproducedbyangiotensin17inwaterloadedrats‏ ‎‡A Effect of selective angiotensin antagonists on the antidiuresis produced by angiotensin-(1-7) in water-loaded rats‏ ‎‡9 1‏
919 ‎‡a enzymatichydrolysisofwheyproteinconcentrateeffectofenzymetypeandenzymesubstrateratioonpeptideprofile‏ ‎‡A Enzymatic hydrolysis of whey protein concentrate: effect of enzyme type and enzyme:substrate ratio on peptide profile‏ ‎‡9 1‏
919 ‎‡a erratumtomesangialc4ddepositionmaypredictprogressionofkidneydiseaseinpediatricpatientswithiganephropathy‏ ‎‡A Erratum to: mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏ ‎‡9 1‏
919 ‎‡a evaluationofcreatininebasedandcystatin100basedequationsforestimationofglomerularfiltrationrateintype1diabeticpatients‏ ‎‡A Evaluation of creatinine-based and cystatin C-based equations for estimation of glomerular filtration rate in type 1 diabetic patients‏ ‎‡9 1‏
919 ‎‡a evidenceforaphysiologicalroleofangiotensin‏ ‎‡A Evidence for a Physiological Role of Angiotensin-‏ ‎‡9 1‏
919 ‎‡a evidenceforaphysiologicalroleofangiotensin17inthecontrolofhydroelectrolytebalance‏ ‎‡A Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance‏ ‎‡9 1‏
919 ‎‡a evidenceforaroleofangiotensinconvertingenzyme2inproteinuriaofidiopathicnephroticsyndrome‏ ‎‡A Evidence for a role of Angiotensin Converting Enzyme 2 in proteinuria of idiopathic nephrotic syndrome‏ ‎‡9 1‏
919 ‎‡a evidenceforinteractionsbetweeninflammatorymarkersandreninangiotensinsystemmoleculesintheoccurrenceofalbuminuriainchildrenwithsicklecellanemia‏ ‎‡A Evidence for interactions between inflammatory markers and renin-angiotensin system molecules in the occurrence of albuminuria in children with sickle cell anemia‏ ‎‡9 1‏
919 ‎‡a 1reportofcollapsingvariantoffocalsegmentalglomerulosclerosistriggeredbyarbovirusdengueandzikavirusinfection‏ ‎‡A First report of collapsing variant of focal segmental glomerulosclerosis triggered by arbovirus: dengue and Zika virus infection.‏ ‎‡9 1‏
919 ‎‡a frequencyofoverweightandobesityinchildrenandadolescentswithautismandattentiondeficithyperactivitydisorder‏ ‎‡A Frequency of overweight and obesity in children and adolescents with autism and attention deficit/hyperactivity disorder‏ ‎‡9 1‏
919 ‎‡a geneticdeletionoftheangiotensin‏ ‎‡A Genetic deletion of the angiotensin-‏ ‎‡9 1‏
919 ‎‡a geneticdeletionoftheangiotensin17receptormasleadstoglomerularhyperfiltrationandmicroalbuminuria‏ ‎‡A Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria.‏ ‎‡9 1‏
919 ‎‡a glomerularhyperfiltrationandβ2microglobulinasbiomarkersofincipientrenaldysfunctionincancersurvivors‏ ‎‡A Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivors‏ ‎‡9 1‏
919 ‎‡a hemodialysisvascularaccessthrombosistheroleoffactor5leidenprothrombingenemutationandabobloodgroups‏ ‎‡A Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.‏ ‎‡9 1‏
919 ‎‡a hemostaticchangesinpatientswithendstagerenaldiseaseundergoinghemodialysis‏ ‎‡A Hemostatic changes in patients with end stage renal disease undergoing hemodialysis‏ ‎‡9 1‏
919 ‎‡a hemostaticparametersaccordingtorenalfunctionandtimeaftertransplantationinbrazilianrenaltransplantedpatients‏ ‎‡A Hemostatic Parameters according to Renal Function and Time after Transplantation in Brazilian Renal Transplanted Patients‏ ‎‡9 1‏
919 ‎‡a hepatorenalsyndromeinchildrenareview‏ ‎‡A Hepatorenal syndrome in children: a review‏ ‎‡9 1‏
919 ‎‡a imagingforevaluationofurologicabnormalitiesininfantswithfetalhydronephrosisadvancesandcontroversies‏ ‎‡A Imaging for evaluation of urologic abnormalities in infants with fetal hydronephrosis: advances and controversies‏ ‎‡9 1‏
919 ‎‡a immunebasedtherapiesfortraumaticbraininjuryinsightsfrompreclinicalstudies‏ ‎‡A Immune-Based Therapies for Traumatic Brain Injury: Insights from pre-clinical studies‏ ‎‡9 1‏
919 ‎‡a immunemarkersintherasopathyneurofibromatosistype1‏ ‎‡A Immune markers in the RASopathy neurofibromatosis type 1.‏ ‎‡9 1‏
919 ‎‡a immunemediatorsinidiopathicnephroticsyndromeevidenceforarelationbetweeninterleukin8andproteinuria‏ ‎‡A Immune Mediators in Idiopathic Nephrotic Syndrome: Evidence for a Relation Between Interleukin 8 and Proteinuria‏ ‎‡9 1‏
919 ‎‡a immunestatusofpatientswithhaemophiliaabeforeexposuretofactor81resultsfromthehemfilstudy‏ ‎‡A Immune status of patients with haemophilia A before exposure to factor VIII: first results from the HEMFIL study.‏ ‎‡9 1‏
919 ‎‡a immunoglobulinanephropathyapathophysiologyview‏ ‎‡A Immunoglobulin A nephropathy: a pathophysiology view‏ ‎‡9 1‏
919 ‎‡a immunoglobulinanephropathypathologicalmarkersofrenalsurvivalinpaediatricpatients‏ ‎‡A Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients‏ ‎‡9 1‏
919 ‎‡a inmemoriamprofessorjosesilveriosantosdiniz‏ ‎‡A [In memoriam: Professor José Silvério Santos Diniz‏ ‎‡9 1‏
919 ‎‡a inmemoriamprofessorjosesilveriosantosdiniz1935‏ ‎‡A [In memoriam: Professor José Silvério Santos Diniz (1935-2011)].‏ ‎‡9 1‏
919 ‎‡a increasedmigratoryandactivationcellmarkersofperipheralbloodlymphocytesinanexperimentalmodelofnephroticsyndrome‏ ‎‡A Increased Migratory and Activation Cell Markers of Peripheral Blood Lymphocytes in an Experimental Model of Nephrotic Syndrome‏ ‎‡9 1‏
919 ‎‡a inflamacaonadoencarenalcronicapapeldecitocinas‏ ‎‡A Inflamação na doença renal crônica: papel de citocinas‏ ‎‡9 1‏
919 ‎‡a inflammatorymoleculesandneurotrophicfactorsasbiomarkersofneuropsychomotordevelopmentinpretermneonatesasystematicreview‏ ‎‡A Inflammatory molecules and neurotrophic factors as biomarkers of neuropsychomotor development in preterm neonates: A Systematic Review.‏ ‎‡9 1‏
919 ‎‡a influenceoface1500polymorphismoncirculatinglevelsofplasminogenactivatorinhibitor1500dimerultrasensitive100reactiveproteinandtransforminggrowthfactorβ1inpatientsundergoinghemodialysis‏ ‎‡A Influence of ACE I/D Polymorphism on Circulating Levels of Plasminogen Activator Inhibitor 1, D-Dimer, Ultrasensitive C-Reactive Protein and Transforming Growth Factor β1 in Patients Undergoing Hemodialysis‏ ‎‡9 1‏
919 ‎‡a interactionsbetweencytokinescongenitalanomaliesofkidneyandurinarytractandchronickidneydisease‏ ‎‡A Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease‏ ‎‡9 1‏
919 ‎‡a interactionsbetweenlocalreninangiotensinsystemandnitricoxideinthebrainoftrypanosomacruziinfectedrats‏ ‎‡A Interactions between local renin angiotensin system and nitric oxide in the brain of Trypanosoma cruzi infected rats‏ ‎‡9 1‏
919 ‎‡a iscd44inglomerularparietalepithelialcellsapathologicalmarkerofrenalfunctiondeteriorationinprimaryfocalsegmentalglomerulosclerosis‏ ‎‡A Is CD44 in glomerular parietal epithelial cells a pathological marker of renal function deterioration in primary focal segmental glomerulosclerosis?‏ ‎‡9 1‏
919 ‎‡a isremifentanilanoptionforpremedicationforneonatalendotrachealintubation‏ ‎‡A Is remifentanil an option for premedication for neonatal endotracheal intubation?‏ ‎‡9 1‏
919 ‎‡a isthereacorrelationbetweenjournalimpactfactorandresearchersperformanceastudycomprisingthefieldsofclinicalnephrologyandneurosciences‏ ‎‡A Is there a correlation between journal impact factor and researchers’ performance? A study comprising the fields of clinical nephrology and neurosciences‏ ‎‡9 1‏
919 ‎‡a kidneybrainaxisinflammatorycrosstalkfrombenchtobedside‏ ‎‡A Kidney-brain axis inflammatory cross-talk: from bench to bedside‏ ‎‡9 1‏
919 ‎‡a liddlessyndromelatediagnosisofararecauseofarterialhypertension‏ ‎‡A Liddle's syndrome: late diagnosis of a rare cause of arterial hypertension‏ ‎‡9 1‏
919 ‎‡a lowurinarylevelsofangiotensinconvertingenzyme2maycontributetoalbuminuriainchildrenwithsicklecellanaemia‏ ‎‡A Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia‏ ‎‡9 1‏
919 ‎‡a lowercirculatinglevelsofangiotensinconvertingenzyme‏ ‎‡A Lower circulating levels of angiotensin-converting enzyme‏ ‎‡9 1‏
919 ‎‡a lowercirculatinglevelsofangiotensinconvertingenzymeaceinpatientswithschizophrenia‏ ‎‡A Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia‏ ‎‡9 1‏
919 ‎‡a masandinflammation‏ ‎‡A Mas and Inflammation‏ ‎‡9 1‏
919 ‎‡a masinthekidney‏ ‎‡A Mas in the Kidney‏ ‎‡9 1‏
919 ‎‡a mascaralaringeaprosealtmcomoviadeadministracaodesurfactantenotratamentodasindromedodesconfortorespiratorioemrecemnascidopretermo‏ ‎‡A Máscara laríngea ProSealTM como via de administração de surfactante no tratamento da síndrome do desconforto respiratório em recém-nascido pré-termo‏ ‎‡9 1‏
919 ‎‡a mesangialc4ddepositionmaypredictprogressionofkidneydiseaseinpediatricpatientswithiganephropathy‏ ‎‡A Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy‏ ‎‡9 1‏
919 ‎‡a morphineversusremifentanilforintubatingpretermneonates‏ ‎‡A Morphine versus remifentanil for intubating preterm neonates‏ ‎‡9 1‏
919 ‎‡a neuropsychiatricdisordersandrenaldiseasesanupdate‏ ‎‡A Neuropsychiatric disorders and renal diseases: an update‏ ‎‡9 1‏
919 ‎‡a neurotrophicfactorsinparkinsonsdiseasewhathavewelearnedfrompreclinicalandclinicalstudies‏ ‎‡A Neurotrophic Factors in Parkinson's Disease: What have we Learned from Pre-Clinical and Clinical Studies?‏ ‎‡9 1‏
919 ‎‡a newmethodofsurgicaldelayedclosureofgiantomphaloceleslazarodasilvastechnique‏ ‎‡A New method of surgical delayed closure of giant omphaloceles: Lazaro da Silva's technique‏ ‎‡9 1‏
919 ‎‡a newerdopplerechocardiographytechniquesinassessmentofheartfunctioninobesepatients‏ ‎‡A Newer Doppler echocardiography techniques in assessment of heart function in obese patients‏ ‎‡9 1‏
919 ‎‡a nonpeptideave0991isanangiotensin‏ ‎‡A Nonpeptide AVE 0991 is an angiotensin-‏ ‎‡9 1‏
919 ‎‡a nonpeptideave0991isanangiotensin17receptormasagonistinthemousekidney‏ ‎‡A Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.‏ ‎‡9 1‏
919 ‎‡a nutritionalevaluationofchildrenwithchroniccholestaticdisease‏ ‎‡A Nutritional evaluation of children with chronic cholestatic disease‏ ‎‡9 1‏
919 ‎‡a pathophysiologyofarterialhypertensioninsightsfrompediatricstudies‏ ‎‡A Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies‏ ‎‡9 1‏
919 ‎‡a pax2polymorphismsandcongenitalabnormalitiesofthekidneyandurinarytractinabrazilianpediatricpopulationevidenceforaroleinvesicoureteralreflux‏ ‎‡A PAX2 polymorphisms and congenital abnormalities of the kidney and urinary tract in a Brazilian pediatric population: evidence for a role in vesicoureteral reflux‏ ‎‡9 1‏
919 ‎‡a pediatriclupusnephritis‏ ‎‡A Pediatric lupus nephritis‏ ‎‡9 1‏
919 ‎‡a pediatricpatientswithsteroidsensitivenephroticsyndromehavehigherexpressionoftregulatorylymphocytesincomparisontosteroidresistantdisease‏ ‎‡A Pediatric Patients With Steroid-Sensitive Nephrotic Syndrome Have Higher Expression of T Regulatory Lymphocytes in Comparison to Steroid-Resistant Disease‏ ‎‡9 1‏
919 ‎‡a perfileanalisedaproducaocientifica2pesquisadoresbrasileirosemneurocienciaclinica‏ ‎‡A Perfil e análise da produção científica dos pesquisadores brasileiros em Neurociência Clínica‏ ‎‡9 1‏
919 ‎‡a peripherallevelsofangiotensinsareassociatedwithdepressivesymptomsinparkinsonsdisease‏ ‎‡A Peripheral levels of angiotensins are associated with depressive symptoms in Parkinson's disease‏ ‎‡9 1‏
919 ‎‡a physicalexerciseandace2angiotensin‏ ‎‡A Physical Exercise and ACE2-Angiotensin-‏ ‎‡9 1‏
919 ‎‡a physicalexerciseandace2angiotensin17masreceptoraxisofthereninangiotensinsystem‏ ‎‡A Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System‏ ‎‡9 1‏
919 ‎‡a plasmaandcerebrospinalfluidlevelsofcytokinesasdiseasemarkersofneurologicmanifestationinlongtermhtlv1infectedindividuals‏ ‎‡A Plasma and cerebrospinal fluid levels of cytokines as disease markers of neurologic manifestation in long-term HTLV-1 infected individuals.‏ ‎‡9 1‏
919 ‎‡a plasmaandurinarylevelsofcytokinesinpatientswithidiopathichypercalciuria‏ ‎‡A Plasma and urinary levels of cytokines in patients with idiopathic hypercalciuria‏ ‎‡9 1‏
919 ‎‡a plasmalevelsofalarminil33areunchangedinautismspectrumdisorderapreliminarystudy‏ ‎‡A Plasma levels of alarmin IL-33 are unchanged in autism spectrum disorder: a preliminary study‏ ‎‡9 1‏
919 ‎‡a posteriorurethralvalveinfetusesevidencefortheroleofinflammatorymolecules‏ ‎‡A Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules‏ ‎‡9 1‏
919 ‎‡a posteriorurethralvalvescomparisonofclinicaloutcomesbetweenpostnatalandantenatalcohorts‏ ‎‡A Posterior urethral valves: comparison of clinical outcomes between postnatal and antenatal cohorts‏ ‎‡9 1‏
919 ‎‡a potentialroleofnutrientintakeandmalnutritionaspredictorsofuremicoxidativetoxicityinpatientswithendstagerenaldisease‏ ‎‡A Potential Role of Nutrient Intake and Malnutrition as Predictors of Uremic Oxidative Toxicity in Patients with End-Stage Renal Disease‏ ‎‡9 1‏
919 ‎‡a predictivefactorsofchronickidneydiseaseinseverevesicoureteralreflux‏ ‎‡A Predictive factors of chronic kidney disease in severe vesicoureteral reflux‏ ‎‡9 1‏
919 ‎‡a predictivefactorsofprogressiontochronickidneydiseasestage5inapredialysisinterdisciplinaryprogramme‏ ‎‡A Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme‏ ‎‡9 1‏
919 ‎‡a primaryversussecondaryhypertensioninchildrenfollowedupatanoutpatienttertiaryunit‏ ‎‡A Primary versus secondary hypertension in children followed up at an outpatient tertiary unit‏ ‎‡9 1‏
919 ‎‡a profileandscientificoutputofresearchersrecipientsofcnpqproductivitygrantinthefieldofmedicine‏ ‎‡A Profile and scientific output of researchers recipients of CNPq productivity grant in the field of medicine‏ ‎‡9 1‏
919 ‎‡a profileandscientificproductionofthebraziliancouncilforscientificandtechnologicaldevelopmentcnpqresearchersinthefieldofhematologyoncology‏ ‎‡A Profile and scientific production of the Brazilian Council for Scientific and Technological Development (CNPq) researchers in the field of Hematology/Oncology‏ ‎‡9 1‏
919 ‎‡a rasinthecentralnervoussystempotentialroleinneuropsychiatricdisorders‏ ‎‡A RAS in the Central Nervous System: Potential Role in Neuropsychiatric Disorders‏ ‎‡9 1‏
919 ‎‡a recentadvancesintheangiotensinconvertingenzyme2angiotensin‏ ‎‡A Recent advances in the angiotensin-converting enzyme 2-angiotensin‏ ‎‡9 1‏
919 ‎‡a recentadvancesintheangiotensinconvertingenzyme2angiotensin17masaxis‏ ‎‡A Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenabobloodgroupsandvonwillebrandfactoradamts13andfactor8inpatientsundergoinghemodialysis‏ ‎‡A Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenangiotensin‏ ‎‡A Relationship between angiotensin-‏ ‎‡9 1‏
919 ‎‡a relationshipbetweenangiotensin17andangiotensin2correlateswithhemodynamicchangesinhumanlivercirrhosis‏ ‎‡A Relationship between angiotensin-(1-7) and angiotensin II correlates with hemodynamic changes in human liver cirrhosis‏ ‎‡9 1‏
919 ‎‡a remifentanilforsedationandanalgesiainapretermneonatewithrespiratorydistresssyndrome‏ ‎‡A Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome‏ ‎‡9 1‏
919 ‎‡a renalactionsofangiotensin‏ ‎‡A Renal actions of angiotensin-‏ ‎‡9 1‏
919 ‎‡a renalactionsofangiotensin17‏ ‎‡A Renal actions of angiotensin-(1-7).‏ ‎‡9 1‏
919 ‎‡a renalfunctionintransgenicratsexpressinganangiotensin‏ ‎‡A Renal function in transgenic rats expressing an angiotensin-‏ ‎‡9 1‏
919 ‎‡a renalfunctionintransgenicratsexpressinganangiotensin17producingfusionprotein‏ ‎‡A Renal function in transgenic rats expressing an angiotensin-(1–7)-producing fusion protein‏ ‎‡9 1‏
919 ‎‡a renalsympatheticdenervationforresistanthypertensionwheredowestandaftermorethanadecade‏ ‎‡A Renal sympathetic denervation for resistant hypertension: where do we stand after more than a decade‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsystemandalzheimersdiseasepathophysiologyfromthepotentialinteractionstotherapeuticperspectives‏ ‎‡A Renin-angiotensin system and Alzheimer's disease pathophysiology: From the potential interactions to therapeutic perspectives‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsystemandcytokinesinchronickidneydiseaseclinicalandexperimentalevidence‏ ‎‡A Renin Angiotensin System and Cytokines in Chronic Kidney Disease: Clinical and Experimental Evidence‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsysteminliverdiseasesfriendorfoe‏ ‎‡A Renin angiotensin system in liver diseases: Friend or foe?‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsysteminthepathogenesisofliverfibrosis‏ ‎‡A Renin-angiotensin system in the pathogenesis of liver fibrosis‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsystemrasandimmunesystemprofileinspecificsubgroupswithcovid19‏ ‎‡A Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19‏ ‎‡9 1‏
919 ‎‡a renoprotectiveeffectsofave0991anonpeptidemasreceptoragonistinexperimentalacuterenalinjury‏ ‎‡A Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury.‏ ‎‡9 1‏
919 ‎‡a riskfactorsforearlyonsetofdiabeticnephropathyinpediatrictype1diabetes‏ ‎‡A Risk factors for early onset of diabetic nephropathy in pediatric type 1 diabetes‏ ‎‡9 1‏
919 ‎‡a riskfactorsforrecurrenturinarytractinfectionsinacohortofpatientswithprimaryvesicoureteralreflux‏ ‎‡A Risk factors for recurrent urinary tract infections in a cohort of patients with primary vesicoureteral reflux.‏ ‎‡9 1‏
919 ‎‡a riskofhypertensioninprimaryvesicoureteralreflux‏ ‎‡A Risk of hypertension in primary vesicoureteral reflux‏ ‎‡9 1‏
919 ‎‡a sedationandanalgesiainneonatology‏ ‎‡A [Sedation and analgesia in neonatology.].‏ ‎‡9 1‏
919 ‎‡a serumlevelsofangiotensinconvertingenzymeasabiomarkerofliverfibrosis‏ ‎‡A Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis‏ ‎‡9 1‏
919 ‎‡a sicklecelldiseasenephropathyanupdateonriskfactorsandpotentialbiomarkersinpediatricpatients‏ ‎‡A Sickle cell disease nephropathy: an update on risk factors and potential biomarkers in pediatric patients‏ ‎‡9 1‏
919 ‎‡a solubletumornecrosisfactorreceptorsareassociatedwithseverityofkidneydysfunctioninpediatricchronickidneydisease‏ ‎‡A Soluble tumor necrosis factor receptors are associated with severity of kidney dysfunction in pediatric chronic kidney disease‏ ‎‡9 1‏
919 ‎‡a studyoftheassociationbetweenthebmp4geneandcongenitalanomaliesofthekidneyandurinarytract‏ ‎‡A Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract‏ ‎‡9 1‏
919 ‎‡a successfulmanagementofconcomitantomphaloceleaccessoryhepaticlobeandbiliaryatresiaina44dayoldboy‏ ‎‡A Successful management of concomitant omphalocele, accessory hepatic lobe, and biliary atresia in a 44-day-old boy.‏ ‎‡9 1‏
919 ‎‡a tlymphocyteexpressinginflammatorycytokinesunderliepersistenceofproteinuriainchildrenwithidiopathicnephroticsyndrome‏ ‎‡A T-lymphocyte-expressing inflammatory cytokines underlie persistence of proteinuria in children with idiopathic nephrotic syndrome‏ ‎‡9 1‏
919 ‎‡a antiinflammatorypotentialoface2angiotensin17masreceptoraxisevidencefrombasicandclinicalresearch‏ ‎‡A The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research‏ ‎‡9 1‏
919 ‎‡a experimentalmodelofnephroticsyndromeinducedbydoxorubicininrodentsanupdate‏ ‎‡A The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update‏ ‎‡9 1‏
919 ‎‡a oxfordclassificationpredictorsofchronickidneydiseaseinpediatricpatientswithiganephropathy‏ ‎‡A The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy‏ ‎‡9 1‏
919 ‎‡a pregnancyinducedincreaseofplasmaangiotensin‏ ‎‡A The pregnancy-induced increase of plasma angiotensin-‏ ‎‡9 1‏
919 ‎‡a pregnancyinducedincreaseofplasmaangiotensin17isbluntedingestationaldiabetes‏ ‎‡A The pregnancy-induced increase of plasma angiotensin-(1–7) is blunted in gestational diabetes‏ ‎‡9 1‏
919 ‎‡a protectivearmofthereninangiotensinsystemmaycounteracttheintenseinflammatoryprocessinfetuseswithposteriorurethralvalves‏ ‎‡A The protective arm of the renin–angiotensin system may counteract the intense inflammatory process in fetuses with posterior urethral valves‏ ‎‡9 1‏
919 ‎‡a reninangiotensinaldosteronesystemin2011roleinhypertensionandchronickidneydisease‏ ‎‡A The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsystemandbipolardisorderasystematicreview‏ ‎‡A The Renin Angiotensin System and Bipolar Disorder: A Systematic Review‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsystemandthecerebrovasculardiseasesexperimentalandclinicalevidence‏ ‎‡A The Renin-Angiotensin System and the Cerebrovascular Diseases: Experimental and Clinical Evidence‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsysteminaratmodelofhepaticfibrosisevidenceforaprotectiveroleofangiotensin‏ ‎‡A The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsysteminaratmodelofhepaticfibrosisevidenceforaprotectiveroleofangiotensin17‏ ‎‡A The renin–angiotensin system in a rat model of hepatic fibrosis: Evidence for a protective role of Angiotensin-(1–7)‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsysteminchildhoodhypertensionselectiveincreaseofangiotensin‏ ‎‡A The renin angiotensin system in childhood hypertension: selective increase of angiotensin-‏ ‎‡9 1‏
919 ‎‡a reninangiotensinsysteminchildhoodhypertensionselectiveincreaseofangiotensin17inessentialhypertension‏ ‎‡A The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension.‏ ‎‡9 1‏
919 ‎‡a roleofgeneticandimmunefactorsforthepathogenesisofprimarysclerosingcholangitisinchildhood‏ ‎‡A The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood‏ ‎‡9 1‏
919 ‎‡a roleoftheimmunesysteminidiopathicnephroticsyndromeareviewofclinicalandexperimentalstudies‏ ‎‡A The role of the immune system in idiopathic nephrotic syndrome: a review of clinical and experimental studies‏ ‎‡9 1‏
919 ‎‡a therapeuticpotentialofangiotensin17asanovelreninangiotensinsystemmediator‏ ‎‡A The therapeutic potential of Angiotensin-(1-7) as a novel Renin-Angiotensin System mediator‏ ‎‡9 1‏
919 ‎‡a therapeuticroleofreninangiotensinsystemblockersinobesityrelatedrenaldisorders‏ ‎‡A The therapeutic role of Renin-Angiotensin System blockers in obesity- related renal disorders‏ ‎‡9 1‏
919 ‎‡a typicalfeaturesofamelogenesisimperfectain2patientswithbartterssyndrome‏ ‎‡A Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter's Syndrome‏ ‎‡9 1‏
919 ‎‡a updateontheapproachofurinarytractinfectioninchildhood‏ ‎‡A Update on the approach of urinary tract infection in childhood‏ ‎‡9 1‏
919 ‎‡a urinarychemokinesandantiinflammatorymoleculesinrenaltransplantedpatientsaspotentialbiomarkersofgraftfunctionaprospectivestudy‏ ‎‡A Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study‏ ‎‡9 1‏
919 ‎‡a urinarylevelsofil1βandgdnfinpretermneonatesaspotentialbiomarkersofmotordevelopmentaprospectivestudy‏ ‎‡A Urinary Levels of IL-1β and GDNF in Preterm Neonates as Potential Biomarkers of Motor Development: A Prospective Study.‏ ‎‡9 1‏
919 ‎‡a urinarylevelsoftgfβ1andofcytokinesinpatientswithprenatallydetectednephrouropathies‏ ‎‡A Urinary levels of TGF β-1 and of cytokines in patients with prenatally detected nephrouropathies‏ ‎‡9 1‏
919 ‎‡a urinarytractinfectioninpediatricsanoverview‏ ‎‡A Urinary tract infection in pediatrics: an overview‏ ‎‡9 1‏
919 ‎‡a uromodulinanewbiomarkeroffetalrenalfunction‏ ‎‡A Uromodulin: a new biomarker of fetal renal function?‏ ‎‡9 1‏
919 ‎‡a useofdifferentproteasestoobtainwheyproteinconcentratehydrolysateswithinhibitoryactivitytowardangiotensinconvertingenzyme‏ ‎‡A Use of Different Proteases to Obtain Whey Protein Concentrate Hydrolysates with Inhibitory Activity toward Angiotensin-Converting Enzyme‏ ‎‡9 1‏
919 ‎‡a usefulnessofpositronemissiontomographyinthedifferentiationbetweentumorandinfectiouslesionsinpediatriconcologyacasereport‏ ‎‡A Usefulness of positron emission tomography in the differentiation between tumor and infectious lesions in pediatric oncology: a case report‏ ‎‡9 1‏
943 ‎‡a 201x‏ ‎‡A 2011‏ ‎‡9 1‏
946 ‎‡a a‏ ‎‡9 1‏
996 ‎‡2 BLBNB|000552987‏
996 ‎‡2 LC|n 87816266‏
996 ‎‡2 PTBNP|1599459‏
996 ‎‡2 BNF|16689368‏
996 ‎‡2 NII|DA05689778‏
996 ‎‡2 LNB|LNC10-000139303‏
996 ‎‡2 BLBNB|000275430‏
996 ‎‡2 PLWABN|9812667372405606‏
996 ‎‡2 BLBNB|001554006‏
996 ‎‡2 PTBNP|1860618‏
996 ‎‡2 SZ|1185987754‏
996 ‎‡2 BLBNB|000262577‏
996 ‎‡2 PTBNP|213062‏
996 ‎‡2 LC|n 2012069930‏
996 ‎‡2 DNB|1204223955‏
996 ‎‡2 ISNI|0000000400330253‏
996 ‎‡2 ISNI|0000000067668305‏
996 ‎‡2 LC|n 2006049882‏
996 ‎‡2 ISNI|0000000428114448‏
996 ‎‡2 PTBNP|1452605‏
996 ‎‡2 DNB|1251080022‏
996 ‎‡2 BLBNB|001575463‏
996 ‎‡2 BLBNB|001570612‏
996 ‎‡2 LC|nb2011007052‏
996 ‎‡2 ISNI|0000000123305702‏
996 ‎‡2 PTBNP|1358761‏
996 ‎‡2 LC|n 2022251246‏
996 ‎‡2 PTBNP|1834160‏
996 ‎‡2 DNB|1205114629‏
996 ‎‡2 ISNI|000000006743084X‏
996 ‎‡2 PTBNP|1458059‏
996 ‎‡2 PTBNP|1626884‏
996 ‎‡2 BLBNB|001457558‏
996 ‎‡2 BLBNB|001541517‏
996 ‎‡2 ISNI|0000000070019146‏
996 ‎‡2 BLBNB|000505768‏
996 ‎‡2 PTBNP|1657018‏
996 ‎‡2 BLBNB|000489486‏
996 ‎‡2 NII|DA17770953‏
996 ‎‡2 ISNI|0000000114101900‏
996 ‎‡2 ISNI|0000000068281911‏
996 ‎‡2 LC|n 95910490‏
996 ‎‡2 PTBNP|1510028‏
996 ‎‡2 BLBNB|000556822‏
996 ‎‡2 NLA|000035273522‏
996 ‎‡2 ISNI|0000000101224311‏
996 ‎‡2 ISNI|0000000501456939‏
996 ‎‡2 LC|n 2006210628‏
996 ‎‡2 DNB|1333261616‏
996 ‎‡2 BLBNB|001476433‏
996 ‎‡2 BLBNB|001480368‏
996 ‎‡2 NTA|298907755‏
996 ‎‡2 ISNI|0000000111217537‏
996 ‎‡2 PTBNP|145257‏
996 ‎‡2 PTBNP|1620960‏
996 ‎‡2 ISNI|0000000029940777‏
996 ‎‡2 PTBNP|1303223‏
996 ‎‡2 ISNI|0000000070099828‏
996 ‎‡2 LC|n 89298396‏
996 ‎‡2 PTBNP|172181‏
996 ‎‡2 ISNI|0000000427579454‏
996 ‎‡2 LC|no2019134624‏
996 ‎‡2 RERO|A027149798‏
996 ‎‡2 BLBNB|000184655‏
996 ‎‡2 PTBNP|169674‏
996 ‎‡2 PTBNP|1618187‏
996 ‎‡2 DNB|1191839109‏
996 ‎‡2 PTBNP|713538‏
996 ‎‡2 ISNI|0000000082527703‏
996 ‎‡2 BIBSYS|1634281496246‏
996 ‎‡2 PTBNP|1600904‏
996 ‎‡2 ISNI|0000000054975496‏
996 ‎‡2 DNB|115715851X‏
996 ‎‡2 DNB|1219248169‏
996 ‎‡2 DNB|1231837802‏
996 ‎‡2 PLWABN|9813211183605606‏
996 ‎‡2 SZ|1206346442‏
996 ‎‡2 CAOONL|ncf12034707‏
996 ‎‡2 PTBNP|1809085‏
996 ‎‡2 PTBNP|1483891‏
996 ‎‡2 PTBNP|113153‏
996 ‎‡2 J9U|987007274065305171‏
996 ‎‡2 LC|n 2024254835‏
996 ‎‡2 BNF|16641238‏
996 ‎‡2 PTBNP|1687002‏
996 ‎‡2 NUKAT|n 2010158657‏
996 ‎‡2 BLBNB|000612272‏
996 ‎‡2 BNF|14593283‏
996 ‎‡2 LC|n 2014203915‏
996 ‎‡2 PTBNP|869713‏
996 ‎‡2 SUDOC|251638472‏
996 ‎‡2 PLWABN|9811471554305606‏
996 ‎‡2 PTBNP|1238909‏
996 ‎‡2 PTBNP|1233267‏
996 ‎‡2 LC|n 2023251586‏
996 ‎‡2 BLBNB|000438719‏
996 ‎‡2 PTBNP|1844721‏
996 ‎‡2 PTBNP|277213‏
996 ‎‡2 BLBNB|001529932‏
996 ‎‡2 DNB|1292267453‏
996 ‎‡2 PTBNP|1145571‏
996 ‎‡2 LC|no2024009901‏
996 ‎‡2 ISNI|0000000374543473‏
996 ‎‡2 BLBNB|001519977‏
996 ‎‡2 NUKAT|n 2009163135‏
996 ‎‡2 SUDOC|190623985‏
996 ‎‡2 PTBNP|1663880‏
996 ‎‡2 DNB|1060699974‏
996 ‎‡2 BLBNB|001523427‏
996 ‎‡2 SUDOC|161762670‏
996 ‎‡2 BLBNB|000524258‏
996 ‎‡2 ISNI|0000000068295731‏
996 ‎‡2 DNB|1229839933‏
996 ‎‡2 DNB|1324718919‏
996 ‎‡2 PTBNP|1422620‏
996 ‎‡2 ISNI|0000000080886286‏
996 ‎‡2 PTBNP|221766‏
996 ‎‡2 PTBNP|73762‏
996 ‎‡2 PTBNP|951698‏
996 ‎‡2 BLBNB|000352257‏
996 ‎‡2 BLBNB|001572937‏
996 ‎‡2 LC|n 2010202038‏
996 ‎‡2 BLBNB|001475652‏
996 ‎‡2 ISNI|0000000069813297‏
996 ‎‡2 DNB|1018327266‏
996 ‎‡2 ISNI|000000007023708X‏
996 ‎‡2 PTBNP|1011993‏
996 ‎‡2 PTBNP|73968‏
996 ‎‡2 LC|no 00047912‏
996 ‎‡2 ISNI|0000000070397681‏
996 ‎‡2 ISNI|0000000111431824‏
996 ‎‡2 BLBNB|000423422‏
996 ‎‡2 LC|nr 94026954‏
996 ‎‡2 SUDOC|072481218‏
996 ‎‡2 BLBNB|000987715‏
996 ‎‡2 PTBNP|1402744‏
996 ‎‡2 LC|no2006118323‏
996 ‎‡2 ISNI|0000000070614965‏
996 ‎‡2 PTBNP|1767439‏
996 ‎‡2 NTA|421579552‏
996 ‎‡2 PTBNP|1902662‏
996 ‎‡2 ISNI|000000011585754X‏
996 ‎‡2 SUDOC|164117318‏
996 ‎‡2 LC|nb2014014975‏
996 ‎‡2 PTBNP|1339071‏
996 ‎‡2 LC|n 2009220968‏
996 ‎‡2 PTBNP|1493367‏
996 ‎‡2 ISNI|000000051439129X‏
996 ‎‡2 NTA|203884957‏
996 ‎‡2 SUDOC|237722852‏
996 ‎‡2 RERO|A012553159‏
996 ‎‡2 SUDOC|133804321‏
996 ‎‡2 BLBNB|001510713‏
996 ‎‡2 BLBNB|001129691‏
996 ‎‡2 ISNI|0000000036178338‏
996 ‎‡2 BLBNB|001429300‏
996 ‎‡2 SUDOC|259281271‏
996 ‎‡2 ISNI|0000000068112448‏
996 ‎‡2 LC|n 82125070‏
996 ‎‡2 BLBNB|000371046‏
996 ‎‡2 PTBNP|105363‏
996 ‎‡2 ISNI|0000000068913536‏
996 ‎‡2 ISNI|0000000069294132‏
996 ‎‡2 ISNI|0000000068174091‏
996 ‎‡2 ISNI|0000000039010960‏
996 ‎‡2 NTA|422949795‏
996 ‎‡2 PTBNP|1733715‏
996 ‎‡2 BLBNB|000350561‏
996 ‎‡2 NTA|070055645‏
996 ‎‡2 BLBNB|001538060‏
996 ‎‡2 BLBNB|001590114‏
996 ‎‡2 ISNI|0000000070398000‏
996 ‎‡2 CAOONL|ncf11968826‏
996 ‎‡2 PTBNP|1750509‏
996 ‎‡2 ISNI|0000000081325034‏
996 ‎‡2 ISNI|0000000046636064‏
996 ‎‡2 ISNI|0000000428275866‏
996 ‎‡2 LC|no2014160488‏
996 ‎‡2 ISNI|0000000077588149‏
996 ‎‡2 PTBNP|1339524‏
996 ‎‡2 BNF|17933761‏
996 ‎‡2 BLBNB|000372741‏
996 ‎‡2 DNB|1218560037‏
996 ‎‡2 LC|n 2015235604‏
996 ‎‡2 DNB|1254074392‏
996 ‎‡2 DNB|124910839X‏
996 ‎‡2 RERO|A023738957‏
996 ‎‡2 SUDOC|224522124‏
996 ‎‡2 SUDOC|262274221‏
996 ‎‡2 DNB|1089623151‏
996 ‎‡2 PTBNP|1683489‏
996 ‎‡2 PLWABN|9811302118705606‏
996 ‎‡2 BNF|12282742‏
996 ‎‡2 BLBNB|000603813‏
996 ‎‡2 PTBNP|1431048‏
996 ‎‡2 LC|no2017041559‏
996 ‎‡2 PTBNP|1887809‏
996 ‎‡2 DNB|1056231262‏
996 ‎‡2 NSK|000505712‏
996 ‎‡2 SUDOC|254658881‏
996 ‎‡2 LC|n 2013186072‏
996 ‎‡2 ISNI|0000000044363373‏
996 ‎‡2 PTBNP|1851295‏
996 ‎‡2 BNE|XX1411843‏
996 ‎‡2 BLBNB|001029724‏
996 ‎‡2 LC|no2022006047‏
996 ‎‡2 J9U|987012501074305171‏
996 ‎‡2 PTBNP|967852‏
996 ‎‡2 DNB|112928610X‏
996 ‎‡2 DNB|1068798696‏
996 ‎‡2 PTBNP|266171‏
996 ‎‡2 BLBNB|000262150‏
996 ‎‡2 PTBNP|68151‏
996 ‎‡2 LC|n 2016185333‏
996 ‎‡2 BLBNB|001455954‏
996 ‎‡2 ISNI|0000000031515980‏
996 ‎‡2 LC|no2011171638‏
996 ‎‡2 ISNI|0000000047770847‏
996 ‎‡2 ISNI|0000000034792836‏
996 ‎‡2 SUDOC|136738230‏
996 ‎‡2 ISNI|0000000076937319‏
996 ‎‡2 NUKAT|n 2008089705‏
996 ‎‡2 LC|no2022092465‏
996 ‎‡2 RERO|A026226967‏
996 ‎‡2 ISNI|0000000070513435‏
996 ‎‡2 LC|no2004066431‏
996 ‎‡2 BLBNB|000521626‏
996 ‎‡2 PTBNP|1901159‏
996 ‎‡2 PTBNP|1497071‏
996 ‎‡2 PTBNP|1351981‏
996 ‎‡2 J9U|987007372095205171‏
996 ‎‡2 LC|no2017149185‏
996 ‎‡2 ISNI|0000000079920512‏
996 ‎‡2 BIBSYS|99055241‏
996 ‎‡2 BLBNB|000534747‏
996 ‎‡2 BNCHL|10000000000000000269000‏
996 ‎‡2 BLBNB|000246553‏
996 ‎‡2 ISNI|0000000069516217‏
996 ‎‡2 LC|no2015040128‏
996 ‎‡2 PTBNP|1497415‏
996 ‎‡2 PTBNP|1420479‏
996 ‎‡2 PTBNP|178550‏
996 ‎‡2 LC|n 2022250712‏
996 ‎‡2 PTBNP|1567618‏
996 ‎‡2 BIBSYS|1015219‏
996 ‎‡2 BLBNB|001576133‏
996 ‎‡2 ISNI|0000000068584285‏
996 ‎‡2 NUKAT|n 2021007740‏
996 ‎‡2 LC|n 2007214420‏
996 ‎‡2 DNB|122891333‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏